About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cytometry Part B - Clinical Cytometry
›
top-articles
Cytometry Part B - Clinical Cytometry
2.3
(top 20%)
impact factor
1.0K
(top 20%)
papers
19.6K
(top 10%)
citations
61
(top 10%)
h
-index
2.4
(top 20%)
impact factor
1.2K
all documents
20.9K
doc citations
90
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry
Cytometry Part B - Clinical Cytometry
2005
277
2
Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic
Cytometry Part B - Clinical Cytometry
2010
258
3
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Cytometry Part B - Clinical Cytometry
2013
236
4
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry
Cytometry Part B - Clinical Cytometry
2010
195
5
2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia
Cytometry Part B - Clinical Cytometry
2007
194
6
Considerations for the control of background fluorescence in clinical flow cytometry
Cytometry Part B - Clinical Cytometry
2009
190
7
Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry data
Cytometry Part B - Clinical Cytometry
2010
178
8
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for
MRD
detection in multiple myeloma
Cytometry Part B - Clinical Cytometry
2016
177
9
Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow
Cytometry Part B - Clinical Cytometry
2006
155
10
Flowcytometric phenotyping of common variable immunodeficiency
Cytometry Part B - Clinical Cytometry
2008
155
11
Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria
Cytometry Part B - Clinical Cytometry
2013
153
12
Basophil activation test by flow cytometry: Present and future applications in allergology
Cytometry Part B - Clinical Cytometry
2008
149
13
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
Cytometry Part B - Clinical Cytometry
2016
144
14
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
Cytometry Part B - Clinical Cytometry
2018
133
15
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible
Cytometry Part B - Clinical Cytometry
2008
132
16
B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral blood
Cytometry Part B - Clinical Cytometry
2010
126
17
Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry
Cytometry Part B - Clinical Cytometry
2016
118
18
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
Cytometry Part B - Clinical Cytometry
2005
113
19
Kinetics of H2AX phosphorylation after exposure to cisplatin
Cytometry Part B - Clinical Cytometry
2009
113
20
Practical guidelines for the high‐sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry
Cytometry Part B - Clinical Cytometry
2012
112
21
Markers and function of human NK cells in normal and pathological conditions
Cytometry Part B - Clinical Cytometry
2017
110
22
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell‐related disorders
Cytometry Part B - Clinical Cytometry
2010
109
23
Flow cytometric characterization of cerebrospinal fluid cells
Cytometry Part B - Clinical Cytometry
2011
108
24
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
Cytometry Part B - Clinical Cytometry
2016
108
25
Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part III – analytical issues
Cytometry Part B - Clinical Cytometry
2013
101
26
Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria
Cytometry Part B - Clinical Cytometry
2006
97
27
External quality assurance of circulating tumor cell enumeration using the CellSearch
®
system: A feasibility study
Cytometry Part B - Clinical Cytometry
2011
97
28
AIEOP
‐
BFM
Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia
Cytometry Part B - Clinical Cytometry
2018
96
29
2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications
Cytometry Part B - Clinical Cytometry
2007
95
30
Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels
Cytometry Part B - Clinical Cytometry
2005
93
31
Detection of minimal residual disease in pediatric acute lymphoblastic leukemia
Cytometry Part B - Clinical Cytometry
2013
92
32
Luminex technology for anti-HLA antibody screening: Evaluation of performance and of impact on laboratory routine
Cytometry Part B - Clinical Cytometry
2007
90
33
Single cell analysis of human tissues and solid tumors with mass cytometry
Cytometry Part B - Clinical Cytometry
2017
89
34
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs
Cytometry Part B - Clinical Cytometry
2009
88
35
Indirect immunofluorescence in autoimmune diseases: Assessment of digital images for diagnostic purpose
Cytometry Part B - Clinical Cytometry
2007
87
36
Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)
Cytometry Part B - Clinical Cytometry
2010
86
37
An image analysis approach for automatic malignancy determination of prostate pathological images
Cytometry Part B - Clinical Cytometry
2007
85
38
A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy
Cytometry Part B - Clinical Cytometry
2018
84
39
Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group
Cytometry Part B - Clinical Cytometry
2005
82
40
Diagnosing PNH with FLAER and multiparameter flow cytometry
Cytometry Part B - Clinical Cytometry
2007
82
41
CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping
Cytometry Part B - Clinical Cytometry
2019
82
42
Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses
Cytometry Part B - Clinical Cytometry
2009
81
43
Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy
Cytometry Part B - Clinical Cytometry
2007
80
44
Extended immunophenotyping reference values in a healthy pediatric population
Cytometry Part B - Clinical Cytometry
2019
79
45
Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix
Cytometry Part B - Clinical Cytometry
2006
78
46
Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples
Cytometry Part B - Clinical Cytometry
2013
78
47
Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring
Cytometry Part B - Clinical Cytometry
2005
77
48
CD203c‐based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulation
Cytometry Part B - Clinical Cytometry
2010
77
49
Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy
Cytometry Part B - Clinical Cytometry
2005
76
50
Sepsis‐induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy
Cytometry Part B - Clinical Cytometry
2016
76
site/software ©
exaly
; All materials licenced under
CC by-SA
.